跳至主要内容
临床试验/ISRCTN74504989
ISRCTN74504989已完成未知

A very brief face to face intervention, followed by a text message and/or app intervention to support medication adherence in people prescribed treatment for hypertension in primary care

niversity of Cambridge0 个研究点目标入组 101 人开始时间: 2019年2月25日最近更新:
适应症

试验速览

阶段
未知
状态
已完成
发起方
入组人数
101

研究概览

简要总结

2021 Results article in https://pubmed.ncbi.nlm.nih.gov/33903656/ (added 28/04/2021)

研究设计

研究类型
Interventional

入排标准

性别
All

入选标准

  • •Practitioners (practice nurses, health care assistants):
  • •Practitioners will be included if they advise patients with hypertension during annual reviews, medication reviews, blood pressure checks or similar consultations; at least one practitioner will be recruited per practice
  • •Patients (patients with high blood pressure):
  • •Patients will be included if they:
  • •1. Have a diagnosis of HBP, or comorbidities of HBP type 2 diabetes cholesterol
  • •2. Are prescribed at least one antihypertensive medication for at least six months before study recruitment, as confirmed by practice records
  • •3. Have poorly controlled HBP, as indicated by clinical measures
  • •4. Have a good understanding of English
  • •5. Are able to use mobile phones
  • •6. Have the capacity to provide informed consent

排除标准

  • •Patients will be excluded if they:
  • •1. Have blood pressure > 200/100mm Hg, postural HBP (>20 mmHg systolic drop)
  • •2. Have a diagnosis of dementia, aphasia or other cognitive difficulties that could affect study participation
  • •3. Have had a recent severe life-threatening event or are under treatment for another long-term health condition (e.g. cancer)
  • •4. Receive kidney dialysis
  • •5. Take part in another study
  • •6. Plan to move from the area in the next 6 months
  • •7. BP not managed by their GP practice

研究者

发起方
niversity of Cambridge

相似试验

已完成
不适用
A randomised controlled trial and parallel process evaluation to determine whether CFHealthHub, an intervention to help CF patients build better treatment habits, offers any benefit over usual care to adults with CFSpecialty: Respiratory disorders, Primary sub-specialty: Respiratory disordersUKCRC code/ Disease: Congenital Disorders/ Congenital malformations of the respiratory systemRespiratoryCongenital Disorders/ Congenital malformations of the respiratory system
ISRCTN55504164Sheffield Teaching Hospitals NSH Foundation Trust608
已完成
不适用
A low-intervention study of pre-exposure prophylaxis (PrEP) in healthy volunteers at high risk of coronavirus (SARS-CoV-2) infection.COVID-19 (SARS-CoV-2 infection)Infections and InfestationsCOVID-19 (SARS-CoV-2 infection), coronavirus Infection, coronavirus
ISRCTN34160010orth-Western State Medical University named after I.I. Mechnikov99
已完成
不适用
An evaluation of a new approach to reduce antimicrobial prescribing in care home residentsInfections in care home residents and antimicrobial prescribingInfections and Infestations
ISRCTN10441831Queen's University Belfast (UK)50
已完成
不适用
Can a rapid screening strategy improve infection control in critically ill patients?Infection by ESBL or CPE bacteriaInfections and Infestations
ISRCTN23588440Hôpitaux Universitaires de Genève101
已完成
不适用
Metformin for Romanian patients with autosomal dominant polycystic kidney diseaseGenetic DiseasesAutosomal Dominant Polycystic Kidney Disease
ISRCTN93749377Fundeni Clinical institute34